Evaluation of microdilution and disk diffusion methods for antifungal susceptibility testing of dermatophytes

Medical Mycology

Volumn 45, Issue 7, 2007, Pages 595-602

  Singh, Jagpal ^a   Zaman, Muhammad ^a   Gupta, Aditya K ^a,b  

^a MEDIPROBE RESEARCH INC   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Antifungal susceptibility; Broth microdilution; Dermatophyte; Disk diffusion; Minimal inhibitory concentration

Indexed keywords

AGAR; ANTIFUNGAL AGENT; CICLOPIROX; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; POSACONAZOLE; RAVUCONAZOLE; TERBINAFINE;

ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; DERMATOPHYTE; DIFFUSION; DILUTION; EPIDERMOPHYTON FLOCCOSUM; FUNGAL STRAIN; FUNGUS GROWTH; GROWTH INHIBITION; INTERMETHOD COMPARISON; MICROSPORUM CANIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; QUALITY CONTROL; REPRODUCIBILITY; SPECIES DIFFERENCE; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS; TRICHOPHYTON VIOLACEUM;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; CULTURE MEDIA; MICROBIAL SENSITIVITY TESTS;

ARTHRODERMATACEAE; EPIDERMOPHYTON FLOCCOSUM; MICROSPORUM CANIS; TRICHOPHYTON RUBRUM;

EID: 36549070759     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780701549364     Document Type: Article

References (29)

1. Gupta, AK and Rosso, JQ. Del (2000) An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents. Int J Dermatol, 39, pp. 401-411.
2. Macura, AB. (1995) Dermatophytes, pathogens or saprophytes. Int J Dermatol, 34, pp. 529-530.
3. Weitzman, I. and Summerbell, RC. (1995) The dermatophytes. Clin Microbiol Rev, 8, pp. 240-259.
4. Favre, B., Hofbauer, B., Hildering, KS and Ryder, NS. (2003) Comparison of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes by using a microdilution assay. J Clin Microbiol, 41, pp. 4817-4819.
5. Fernandez-Torres, B., Carrillo, AJ and Martin, E. (2001) In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother, 45, pp. 2524-2528.
6. Gupta, AK and Kohli, Y. (2003) In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity. Br J Dermatol, 149, pp. 296-305.
7. Li, RY, Wan, Z. and Wang, AP (2004) In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China. Mycoses, 47, pp. 402-406.
8. Gupta, AK, Einarson, TR, Summerbell, RC and Shear, NH. (1998) An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs, 55, pp. 645-674.
9. Roberts, DT. (1997) Oral terbinafine (Lamisil) in the treatment of fungal infections of the skin and nails. Dermatology, 194, pp. 37-39.
10. Saul, A., Bonifaz, A. and Arias, I. (1987) Itraconazole in the treatment of superficial mycoses: An open trial of 40 cases. Rev Infect Dis, 9, pp. S100-S103.
11. Ghannoum, MA, Chaturvedi, V. and Espinel-Ingroff, A. (2004) Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes. J Clin Microbiol, 42, pp. 2977-2979.
12. Gupta, AK, Kohli, Y. and Batra, R. (2005) In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species. Med Mycol, 43, pp. 179-185.
13. Perea, S., Fothergill, AW, Sutton, DA and Rinaldi, MG. (2001) Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method. J Clin Microbiol, 39, pp. 385-388.
14. Barchiesi, F., Arzeni, D. and Camiletti, V. (2001) In vitro activity of posaconazole against clinical isolates of dermatophytes. J Clin Microbiol, 39, pp. 4208-4209.
15. Gupta, AK, Leonardi, C., Stoltz, RR, Pierce, PF and Conetta, B. (2005) A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis. J Eur Acad Dermatol Venereol, 19, pp. 437-443.
16. National Committee for Clinical Laboratory Standards (1998) Reference method for broth dilution antifungal susceptibility testing for conidium forming filamentous fungi; proposed standard. NCCLS document M38-P.
17. National Committee for Clinical Laboratory Standards (2002) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi.
18. National Committee for Clinical Laboratory Standards (2004) Reference method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guildeline M44-A (May 2004).
19. Esteban, A., Abarca, ML and Cabanes, FJ. (2005) Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes. Med Mycol, 43, pp. 61-66.
20. Karaca, N. and Koc, AN. (2004) In vitro susceptibility testing of dermatophytes: Comparison of disk diffusion and reference broth dilution methods. Diagn Microbiol Infect Dis, 48, pp. 259-264.
21. Espinel-Ingroff, A., Chaturvedi, V., Fothergill, A. and Rinaldi, MG. (2002) Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study. J Clin Microbiol, 40, pp. 3776-3781.
22. Fernandez-Torres, B., Cabanes, FJ and Carrillo-Munoz, AJ (2002) Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol, 40, pp. 3999-4003.
23. Jessup, CJ, Warner, J., Isham, N., Hasan, I. and Ghannoum, MA. (2000) Antifungal susceptibility testing of dermatophytes: Establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol, 38, pp. 341-344.
24. Norris, HA, Elewski, BE and Ghannoum, MA. (1999) Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method. J Am Acad Dermatol, 40, p. S9.
25. Hazen, KC, Baron, EJ and Colombo, AL (2003) Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion. J Clin Microbiol, 41, pp. 5623-5632.
26. Pfaller, MA, Diekema, DJ, Messer, SA, Boyken, L. and Hollis, RJ. (2003) Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: Report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J Clin Microbiol, 41, pp. 1440-1446.
27. Pfaller, MA, Diekema, DJ and Boyken, L. (2003) Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole. J Clin Microbiol, 41, pp. 1875-1880.
28. Macura, AB. (1993) In vitro susceptibility of dermatophytes to antifungal drugs: A comparison of two methods. Int J Dermatol, 32, pp. 533-536.
29. Chadeganipour, M., Nilipour, S. and Havaei, A. (2004) In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan. Mycoses, 47, pp. 503-507.